Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS-Reference-Cited by-同舟云学术

Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS

Published:2016-02-16 Issue:3 Volume:11 Page:386-394
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Laurin Louis-Philippe,Gasim Adil M.,Poulton Caroline J.,Hogan Susan L.,Jennette J. Charles,Falk Ronald J.,Foster Bethany J.,Nachman Patrick H.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference32 articles.

1. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976–1979 and 1995–1997

2. Focal Segmental Glomerulosclerosis

3. Primary Focal Segmental Glomerulosclerosis: Clinical Course and Response to Therapy

4. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.;Banfi;Clin Nephrol,1991

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collapsing Glomerulopathy;Advances in Kidney Disease and Health;2024-07

2. Kidney Failure Attributed to Focal Segmental Glomerulosclerosis: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic Burden;Kidney Medicine;2024-02

3. Physiologically‐based pharmacokinetic model of sparsentan to evaluate drug–drug interaction potential;CPT: Pharmacometrics & Systems Pharmacology;2023-12-02

4. Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis;Frontiers in Immunology;2023-09-19

5. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases;American Journal of Kidney Diseases;2023-08